Global Cancer Therapy Market Size (2024 - 2029)

Cancer Therapy Market Analysis

The Global Cancer Therapy Market size is estimated at USD 220.24 billion in 2024, and is expected to reach USD 409.68 billion by 2029, growing at a CAGR of 10.64% during the forecast period (2024-2029).

The factors driving the growth of the Cancer Market include increasing patient assistance programs (PAPs), increasing government initiatives for cancer awareness, the rising prevalence of cancer worldwide, vital R&D initiatives from key players, and the increasing demand for personalized medicine. For instance, in November 2023, the American Cancer Society introduced a new program, Community Access to Resources, Education, and Support (ACS CARES), which provides quality information and one-on-one support to cancer patients through a mobile application. This program focuses on improving the accessibility of cancer care services to patients and caregivers by improving information. Thus, such initiatives may enhance the adoption of Cancer Therapy and contribute to the growth of the Cancer Therapy Market.

The technological advancements to enhance the planning of personalized medicines fuel the demand and raise its adoption; thus, it is expected to contribute to the market's growth. Artificial intelligence-based technology for Precision Oncology improves healthcare professionals in therapy planning and early multi-cancer diagnostics. It is used in applications such as developing personalized medical products by utilizing patient data to improve the effectiveness and safety of therapy for cancer patients, fueling the demand for Personalized Cancer Treatment.

Furthermore, the growing burden of cancer globally further raises the need for cancer therapies to treat different types of cancers and is anticipated to drive the growth of the Global Cancer Market. For instance, in January 2024, according to the American Cancer Society, over 18 million Americans were reported to have a history of cancer in the year 2022. It is estimated that over 2 million new cancer cases are expected to be diagnosed in the United States in 2024.

Thus, the factors above, such as the rising burden of cancer, the increasing number of government initiatives, and increasing demands for personalized medicine, contribute to the growth of the Cancer Treatment Market during the forecast period. However, the fluctuations in reimbursement policies and the high cost of cancer therapies can impede the market's growth.

Cancer Therapy Industry Segmentation

According to the scope of the report, cancer therapies are drugs that obstruct the growth and augmentation of cancer by interfering with specific molecules, such as DNA or proteins, that are involved in the development or expansion of cancerous cells. These therapies incorporate surgery, chemotherapy, radiation therapy, immunotherapy, and others. The market is segmented by therapy type, cancer type, end user, and geography. The market is segmented by therapy type into immunotherapy, chemotherapy, targeted therapy, hormonal therapy, and other therapy types. By cancer type, the market is segmented into breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer, gynecologic cancer, and other cancer types. By end user, the market is segmented as specialty clinics, hospitals, and cancer and radiation therapy centers. The market is geographically segmented into North America, Europe, Asia-Pacific, South America, the Middle East and Africa. The market size is provided for each segment in terms of USD value.